News

Phathom Pharmaceuticals Shares Updates on Investor Engagement Events

Phathom Pharmaceuticals Shares Updates on Investor Engagement Events

Phathom Pharmaceuticals Announces Investor Conference Participation

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), a biopharmaceutical company dedicated to creating and commercializing groundbreaking therapies for gastrointestinal diseases, has made an exciting announcement regarding its upcoming engagements with investors. The company's management team is set to participate in multiple investor conferences slated for the coming months, allowing them to connect directly with stakeholders and present their innovative vision for addressing GI disorders.

Highlights of Upcoming Conferences

Phathom will be prominently featured in several key industry events. These conferences provide a platform for the company to showcase its pipeline and engage in one-on-one discussions with investors, health care professionals, and other important stakeholders.

Guggenheim’s Inaugural Healthcare Innovation Conference

One of the first major appearances will be at Guggenheim’s inaugural Healthcare Innovation Conference. This event will take place on a date in November, where Phathom's management will engage in various one-on-one meetings throughout the conference. Participants can expect insightful dialogues on the company's future innovations and strategies.

Stifel 2024 Healthcare Conference

Another significant event is the Stifel 2024 Healthcare Conference scheduled for mid-November. Here, the Phathom team will also facilitate one-on-one interactions, enabling detailed discussions about their pioneering treatments.

International Presence at Jefferies London Healthcare Conference

The company’s reach extends internationally, with participation confirmed in the Jefferies London Healthcare Conference. This event highlights Phathom's commitment to sharing its vision and updates, offering yet another opportunity for face-to-face discussions with global investors.

Engagement at Evercore HealthCONx Conference

Wrapping up their conference engagements, Phathom will be part of the Evercore HealthCONx Conference in early December. This event promises to be an impactful platform for disseminating valuable information about their ongoing projects and future plans.

About Phathom Pharmaceuticals and Its Innovative Therapies

At the core of Phathom Pharmaceuticals' mission is the development and commercialization of novel treatments intended to benefit patients suffering from gastrointestinal illnesses. The company's flagship product, VOQUEZNA, is a first-in-class potassium-competitive acid blocker (PCAB) designed to address conditions such as heartburn related to Non-Erosive GERD and more severe gastrointestinal diseases.

Exploring the Impact of VOQUEZNA

Currently marketed as VOQUEZNA tablets, this innovative treatment aids patients in managing heartburn associated with GERD effectively. It works not only for the healing and maintenance of Erosive GERD but also provides relief from H. pylori infections through specialized treatment pak combinations like VOQUEZNA DUAL PAK® and VOQUEZNA TRIPLE PAK®.

Connecting with Phathom Pharmaceuticals

For those interested in attending the live webcasts of these investor conferences or exploring archived recordings, details are accessible through Phathom Pharmaceuticals’ official website. They have made it easy for stakeholders to stay informed by visiting the News & Events section online.

Media and Investor Relations Contacts

Phathom Pharmaceuticals encourages inquiries from media representatives and investors. The main media contact is Nick Benedetto, reachable at 1-877-742-8466 or via email. Investors can connect with Eric Sciorilli at the same phone number to discuss investment opportunities and insights.

Frequently Asked Questions

What is Phathom Pharmaceuticals known for?

Phathom Pharmaceuticals focuses on developing innovative treatments specifically for gastrointestinal diseases, particularly through its flagship product VOQUEZNA.

When are the upcoming investor conferences?

The company is participating in several conferences in November and December, including major events hosted by Guggenheim and Stifel.

How can I access the investor conference webcasts?

Webcasts and archived recordings can be found on the Phathom Pharmaceuticals website under their News & Events section.

What innovative products does Phathom offer?

Phathom offers VOQUEZNA, a first-in-class PCAB used for treating heartburn and Erosive GERD, along with adjunctive therapies in combination packs.

Who should I contact for media inquiries?

Media inquiries should be directed to Nick Benedetto, who can be reached at 1-877-742-8466 or through email for more information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Global Push to End Holiday Hunger: A Crucial Initiative

Updated Category News Views 76

Holiday Hunger: A Plight We Must Address I'll tell you what really gets under my skin—watching kids go hungry during what's supposed to be the most joyous time of the year. It's the holiday season, folks, and while many of us are fretting over gift lists, millions of children aren't even sure where their next meal is coming from. That's where Feed the Children's newest...

Continue Reading
Sands China Fosters Cultural Ties with Macau Concert

Updated Category News Views 17

Macao's Wind Music Legacy Hits a High Note Who would've thought—a gathering of 550 musicians from Macao SAR and France could ignite such a dynamic cross-cultural exchange? Celebrating three decades of musical milestones, the Macau Band Directors Association (MBDA) didn't just throw any old concert but a spectacle that took international collaboration to an upscale...

Continue Reading
Ampa One Partners with Wave Neuroscience for PTSD

Updated Category News Views 85

Ampa and Wave Neuroscience Join Forces In a fresh twist on the neurotechnology scene, Ampa's portable TMS system is teaming up with Wave Neuroscience's MeRT to target PTSD. Science and partnership—combined like a decent scotch and a well-done steak, if you ask me. They've got the FDA clearance on their side, and they're bringing it to the clinics without demanding those...

Continue Reading
High Stakes at Bragg Companies' Crane Auction

Updated Category News Views 74

Cranes, Cash, and Competition: Auction Insights Never thought a bunch of cranes and trucks could have me so interested, but here we are staring down one of the big ones this December. Bragg Companies plans to lift the lid on its fleet with an absolute auction conducted by none other than Jeff Martin Auctioneers. If you aren't in the loop, 'absolute' means no min bid,...

Continue Reading
Yellow Phosphorus Market Set for Growth to $6.21B

Updated Category News Views 57

What's Cooking in the Phosphorus Market? Kicking off with some seasoning for your thoughts. Picture this: yellow phosphorus isn't just another chemical compound sitting quietly in a lab fridge. Nope, we've got an industrial powerhouse here, folks. Projected to leap from USD 4.84 billion in 2026 to a hearty USD 6.21 billion by 2031, this market's chugging along at a decent...

Continue Reading
Cell Counting Market Growth: USD 17.71 Billion by 2031

Updated Category News Views 167

The Cell Counting Surge: Money Talks in Science You can't deny it when the numbers speak—a jump from USD 12.39 billion to USD 17.71 billion by 2031 in the cell counting market means something ain't business as usual. That's a robust 7.40% CAGR folks; it's a field being bombarded with innovation. The spark? Automated and advanced cell analysis technology taking the...

Continue Reading
Andersen 400 Series Patio Door Wins 2027 Award

Updated Category News Views 68

Andersen's Winning Streak Continues Ever got that feeling when you see an old player pulling off a brand-new trick in the game they love? That's kind of what Andersen Windows just pulled off with their 400 Series patio door snagging the 2027 Home Reno Award from Good Housekeeping. You could say Andersen's figured out how to keep the classics fresh without losing that...

Continue Reading
ADNOC Gas Doubles Q3 Net Income, Eyes $4B Year-end

Updated Category News Views 36

ADNOC Gas Fires Up Q3 Results with a Double Income Just when you think the market's throwing curveballs, ADNOC Gas comes swinging with a solid double on their net income compared to last quarter. Now that's turning some serious heads. Cranking out $1.34 billion in net income for Q3, they've effectively doubled their performance from just the prior quarter. Operational...

Continue Reading
Denver's Holiday Extravaganza: Lights, Markets, and More!

Updated Category News Views 50

Stepping into Denver's Holiday Magic The holiday spirit descends upon Denver like clockwork each year, and 2026 is no exception—a short drive or flight drops you into a winter wonderland packed with more lights, markets, and cheer than you can shake a sleigh bell at. Visitors and locals alike have a smorgasbord of options to revel in. The Mile High Tree and Drone Shows:...

Continue Reading
Paulex Bio's Grant Fuels Bold Diabetes Research Push

Updated Category News Views 89

Cracking the Diabetes Code: A New Hope Emerging It ain't every day you hear about a biotech outfit snagging an NIH Fast-Track grant with the potential to upend diabetes treatment, but Paulex Bio's recent score turns heads. Their brainchild, PAL-119, promises to tackle diabetes not by slapping a band-aid on symptoms, but by getting to the rotten core of the disease: the...

Continue Reading

Top 5 Most Recently Viewed Articles

Luxand FaceSDK Surpasses Expectations in NIST Testing Results

Updated Category News Views 106

Luxand FaceSDK Shines in Recent Accuracy Evaluations Luxand's FaceSDK has recently demonstrated exceptional capabilities during tests conducted by the National Institute of Standards and Technology (NIST). Achieving remarkable results, the FaceSDK secured a position in the top 21.8% for the challenging Visa-Border Combination test. This specific evaluation juxtaposes visa...

Continue Reading
Martin LeBlanc Takes Charge at 3 Boomerang Capital's Board

Updated Category News Views 815

3 Boomerang Capital Welcomes Martin LeBlanc as New Chairman 3 Boomerang Capital, a private equity firm concentrating on the healthcare sector, has appointed industry veteran Martin LeBlanc as the chairman of its Strategic & Operational Advisory Board. This significant addition highlights the firm’s dedication to enhancing its capabilities in fostering strategic value...

Continue Reading
Trucordia Taps Jay Green as CFO Amid Strategic Growth

Updated Category News Views 51

Jay Green Joins Trucordia as Chief Financial Officer Right outta the gate, it's a power move for Trucordia, snagging Jay Green as their new Chief Financial Officer. This isn't just any shuffle in the deck; bringing aboard someone with Green's chops is like doubling down when the odds are in your favor. He's stepping into a company that's perched as a top 20 U.S. insurance...

Continue Reading
Musk's $1 Million Giveaway Faces Legal Challenges Ahead of Elections

Updated Category News Views 64

Musk's Legal Battle Over $1 Million Voter Giveaway Elon Musk, the renowned entrepreneur and CEO of Tesla, is set to attend a crucial court hearing soon. This hearing stems from a legal challenge regarding his ambitious initiative to offer $1 million a day to registered voters in key swing states leading up to a significant U.S. election. The case has garnered substantial...

Continue Reading
SEALSQ Unveils Revolutionary Quantum Root Key for Cybersecurity

Updated Category News Views 177

SEALSQ's Groundbreaking Launch of Quantum Root Key SEALSQ Corp (NASDAQ: LAES), a leader in advanced semiconductor technology, is poised to make significant strides in the realm of cybersecurity. Their collaboration with the OISTE.ORG Foundation aims to elevate the security landscape with their upcoming Post-Quantum Cryptography Root of Trust, known as the Quantum RootCA....

Continue Reading